This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biosteed Gene Expression Tech. Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Lifang Lei: Innovator in Biomedicine
Introduction
Lifang Lei is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biomedicine, particularly in the development of modified interferon therapies. His work focuses on enhancing the efficacy of medical treatments through innovative modifications.
Latest Patents
Lifang Lei holds a patent for "Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof." This invention relates to interferon (IFN)-α2a modified at a specific Lys residue with a Y-shaped branched polyethylene glycol (PEG) derivative. The patent outlines the preparation methods and the use of the modified IFN-α2a in medicinal applications.
Career Highlights
Lifang Lei is associated with Biosteed Gene Expression Tech. Co., Ltd., where he continues to advance his research and development efforts. His innovative approach has led to the creation of therapies that could potentially improve patient outcomes in various medical conditions.
Collaborations
Lifang Lei collaborates with esteemed colleagues, including Weidong Zhou and Qingjiang Xiao, who contribute to his research endeavors. Their combined expertise fosters a productive environment for innovation and discovery.
Conclusion
Lifang Lei's contributions to biomedicine through his patented innovations exemplify the impact of scientific research on healthcare. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile